cytarabine has been researched along with Body Weight in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (58.33) | 18.7374 |
| 1990's | 8 (16.67) | 18.2507 |
| 2000's | 7 (14.58) | 29.6817 |
| 2010's | 5 (10.42) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, L; Peng, S; Wang, Y; Wu, J; Yang, Y; Zhang, X; Zhao, M; Zheng, M | 1 |
| Abhyankar, S; Aljitawi, O; Bivona, C; Bray, WM; Ganguly, S; Grauer, D; Henry, D; Lin, TL; McGuirk, J; Rockey, M; Singh, A | 1 |
| Boehm, U; Bourque, CW; Dimou, L; Djogo, T; Gillon, CJ; Kim, JH; Kokoeva, MV; Kryzskaya, D; Liu, X; Mingay, A; Robins, SC; Schneider, S; Storch, KF; Stroh, T | 1 |
| Abrous, DN; André, C; Castellanos-Jankiewicz, A; Clark, S; Cota, D; Guzman-Quevedo, O; Ladeveze, E; Laye, S; Leste-Lasserre, T; Nadjar, A; Rémus-Borel, J; Rey, C | 1 |
| Ansell, SM; Costa, LJ; Inwards, DJ; Johnston, PB; Litzow, MR; Micallef, IN; Porrata, LF | 1 |
| Aruoma, OI; Fujii, H; Nishioka, H; Sato, E; Sun, B; Wakame, K | 1 |
| Pierce, AA; Xu, AW | 1 |
| BOSTWICK, L; EVANS, JS; MENGEL, GD | 1 |
| Champy, P; Duyckaerts, C; Féger, J; Hirsch, EC; Höglinger, GU; Khondiker, ME; Lannuzel, A; Lombes, A; Medja, F; Michel, PP; Oertel, WH; Prigent, A; Ruberg, M | 1 |
| Flier, JS; Kokoeva, MV; Yin, H | 1 |
| Asano, S; Fukuno, K; Iseki, T; Konuma, T; Ooi, J; Takahashi, S; Tojo, A; Tomonari, A; Tsukada, N; Uchiyama, M | 1 |
| Mego, M; Novotny, L; Rauko, P; Saiko, P; Schott, H; Szekeres, T | 1 |
| Burchenal, JH; Butterbaugh, J; Dollinger, M; Giner-Sorolla, A; Stoll, D | 1 |
| Gray, JW; Ng, CR; Pallavicini, MG | 1 |
| Haustein, B; Helbig, W; Kubel, M; Schultze, W; Schwenke, H; Standke, E; Thierbach, V | 1 |
| Prakash, NJ; Sunkara, PS | 1 |
| Ferrell, J; Gray, LE; Kavlock, RJ; Ostby, J | 1 |
| Howell, SB; King, ME; Naporn, A; Young, B | 1 |
| Barsoum, NJ; DiFonzo, CJ; Gough, AW; Gracon, SI; Sturgess, JM | 1 |
| Braunschweiger, PG; Schenken, LL; Schiffer, LM | 1 |
| Chiang, H; Fu, YD; Lu, DJ; Shao, BJ; Wu, RY; Yao, GD | 1 |
| Abe, T; Kawano, Y; Makimoto, A; Nakagawa, R; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y | 1 |
| Ichikawa, H; Machida, Y; Nagai, T; Onishi, H; Takahata, T | 1 |
| Nagase, S; Saito, T; Sato, S; Watanabe, S | 2 |
| Atkinson, TG; Barker, HJ; Meckling-Gill, KA | 1 |
| Akiyoshi, K; Eguchi, H; Hara, T; Inada, H; Ishii, E; Koga, H; Matsuzaki, A; Miyazaki, S; Nagatoshi, Y; Nakayama, H; Nibu, K; Okamura, J; Take, H; Tamai, Y; Yanai, F | 1 |
| Bezanilla Regato, JL; González Casaseca, T | 1 |
| Caron, N; Kimball, AP; Lee, SH | 1 |
| Mandelli, F | 1 |
| Boggs, DR; Boggs, SS | 1 |
| Adlard, BP; Dobbing, J; Sands, J | 1 |
| Bogden, AE; Carde, P; de Paillette, ED; Frindel, E; Moreau, JP; Tubiana, M | 1 |
| Domingo, JL; Ortega, A; Puig, M | 1 |
| Ang, KK; Landuyt, W; Menten, J; van der Kogel, AJ; van der Schueren, E | 1 |
| Engeset, A; Sønstevold, A; Tanum, G | 1 |
| Berger, MR; Schmähl, D | 1 |
| Chazan, B; Luczak, M; Marcickiewicz, J; Niemiec, T; Sokolska, G; Szmigielski, S; Troszyński, M | 1 |
| Bligham, G; Freireich, EJ; Gehan, E; Hester, JP; Kantarjian, HM; Keating, MJ; McCredie, KB; Smith, TL; Talpaz, M; Walters, RS | 1 |
| Elliott, GA; Gibbons, AJ; Greig, ME | 1 |
| Cannon, JN; Dedrick, RL; el-Dareer, SM; Forrester, DD; Mellett, LB | 1 |
| Ashwal, S; Brunell, PA; Budzilovich, G; Finegold, M; Fish, I | 1 |
| Delamore, IW; Mir, MA | 1 |
| Bagshawe, KD; Woods, RJ | 1 |
| Braine, H; Colvin, M; Davis, PJ; DeFronzo, RA | 1 |
| Dedrick, RL | 1 |
| Hutchison, DJ; Schmid, FA | 1 |
| Biro, V; Goldenberg, DM | 1 |
1 review(s) available for cytarabine and Body Weight
| Article | Year |
|---|---|
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Growth Disorders; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Infant; Japan; Male; Methotrexate; Myelodysplastic Syndromes; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Survivors; Treatment Outcome; Vincristine | 2001 |
1 trial(s) available for cytarabine and Body Weight
| Article | Year |
|---|---|
[Cytosine arabinoside in the treatment of varicella in lymphoblastic leukemia or lymphosarcoma (author's transl)].
Topics: Body Weight; Chickenpox; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Drug Evaluation; Humans; Infant; Injections, Intravenous; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin | 1976 |
46 other study(ies) available for cytarabine and Body Weight
| Article | Year |
|---|---|
A class of Trp-Trp-AA-OBzl: Synthesis, in vitro anti-proliferation/in vivo anti-tumor evaluation, intercalation-mechanism investigation and 3D QSAR analysis.
Topics: Amino Acids; Animals; Antineoplastic Agents; Body Weight; Carbolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytarabine; Differential Thermal Analysis; DNA; Drug Screening Assays, Antitumor; Esters; Humans; Inhibitory Concentration 50; Intercalating Agents; Leukemia, Myeloid; Liver Neoplasms; Male; Melanoma; Mice; Mice, Inbred ICR; Models, Molecular; Neoplasm Transplantation; Organ Size; Quantitative Structure-Activity Relationship | 2011 |
Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Weight; Cohort Studies; Cytarabine; Drug Dosage Calculations; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Obesity; Overweight; Recurrence; Remission Induction; Retrospective Studies; Young Adult | 2015 |
Adult NG2-Glia Are Required for Median Eminence-Mediated Leptin Sensing and Body Weight Control.
Topics: Aging; Animals; Anorexia; Arcuate Nucleus of Hypothalamus; Body Weight; Cell Proliferation; Cytarabine; Dendrites; Electrophysiological Phenomena; Female; Gene Deletion; Leptin; Male; Median Eminence; Mice; Microglia; Mitosis; Neuroglia; Obesity; Phenotype; Receptors, Leptin; Signal Transduction; Weight Gain | 2016 |
Inhibiting Microglia Expansion Prevents Diet-Induced Hypothalamic and Peripheral Inflammation.
Topics: Adiposity; Animals; Antimitotic Agents; Arabinonucleosides; Arcuate Nucleus of Hypothalamus; Body Weight; Cell Proliferation; Cytarabine; Cytidine; Diet, High-Fat; Eating; Hypothalamus; Inflammation; Interleukin-1beta; Leptin; Macrophages, Peritoneal; Male; Mice; Microglia; NF-kappa B; Obesity; Tumor Necrosis Factor-alpha; Weight Gain | 2017 |
Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carmustine; Chi-Square Distribution; Cohort Studies; Cytarabine; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Mucositis; Recurrence; Risk; Statistics, Nonparametric; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2008 |
The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents.
Topics: Alopecia; Animals; Animals, Newborn; Antimetabolites, Antineoplastic; Body Weight; Cytarabine; Female; Hair Follicle; Male; Mercaptopurine; Methotrexate; Mice; Polysaccharides; Rats; Rats, Sprague-Dawley; Shiitake Mushrooms | 2009 |
De novo neurogenesis in adult hypothalamus as a compensatory mechanism to regulate energy balance.
Topics: Absorptiometry, Photon; Adrenocorticotropic Hormone; Agouti-Related Protein; Analysis of Variance; Animals; Animals, Newborn; Antimetabolites, Antineoplastic; Body Composition; Body Weight; Bromodeoxyuridine; Cell Count; Cell Proliferation; Cytarabine; Eating; Energy Metabolism; Hypothalamus; Injections, Intraventricular; Ki-67 Antigen; Mice; Mice, Transgenic; Mutation; Neurogenesis; Neurons; Proliferating Cell Nuclear Antigen; STAT3 Transcription Factor; Time Factors | 2010 |
SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cytarabine; Cytosine; Leukemia; Leukemia L1210; Leukemia, Experimental; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental; Nucleosides; Pharmacology; Porfiromycin; Research; Survival | 1964 |
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.
Topics: alpha-Synuclein; Amyloid beta-Peptides; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Behavior, Animal; Benzothiazoles; Body Weight; Caspase 3; Caspases; Cell Death; Cerebral Cortex; Cytarabine; Diagnostic Imaging; Dopamine and cAMP-Regulated Phosphoprotein 32; Doxorubicin; Dystonia; Electron Transport Complex III; Enzyme Activation; Glial Fibrillary Acidic Protein; Immunohistochemistry; Locomotion; Male; Microscopy, Electron, Transmission; Mitochondria; Neurons; Phosphopyruvate Hydratase; Phosphorylation; Posture; Psychomotor Performance; Rats; Rats, Inbred Lew; Rotenone; tau Proteins; Tauopathies; Thiazoles; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase; Ubiquitin; Uncoupling Agents | 2005 |
Neurogenesis in the hypothalamus of adult mice: potential role in energy balance.
Topics: Animals; Body Weight; Bromodeoxyuridine; Cell Proliferation; Ciliary Neurotrophic Factor; Cytarabine; Doublecortin Domain Proteins; Energy Metabolism; Hypothalamus; Injections, Intraventricular; Leptin; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neurons; Neuropeptide Y; Neuropeptides; Pro-Opiomelanocortin; Receptor, Ciliary Neurotrophic Factor; RNA, Messenger; STAT3 Transcription Factor | 2005 |
Unrelated cord blood transplantation after myeloablative conditioning in patients with acute leukemia aged between 50 and 55 years.
Topics: Acute Disease; Body Weight; Cord Blood Stem Cell Transplantation; Cytarabine; Female; Fetal Blood; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning | 2006 |
In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytarabine; Dimerization; Female; Floxuridine; Inhibitory Concentration 50; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred DBA; Time Factors | 2007 |
Studies of 6-N-hydroxylamino-9-beta-D-ribofuranosylpurine in mouse leukemia.
Topics: Adenine; Animals; Body Weight; Cytarabine; Drug Antagonism; Drug Synergism; Fluorouracil; Guanine; Leukemia; Leukemia L1210; Mercaptopurine; Methotrexate; Mice; Nucleosides; Phosphotransferases; Purines; Vincristine | 1967 |
Relationship between surviving clonogenic crypt fraction and animal lethality after cytosine arabinoside (Ara-C) exposure.
Topics: Animals; Body Weight; Cell Survival; Cytarabine; Female; Intestine, Small; Lethal Dose 50; Mice; Mice, Inbred C3H | 1984 |
[Initial results in allo- and auto-bone marrow transplantation in acute leukemia in East Germany].
Topics: Acute Disease; Adolescent; Adult; Body Weight; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cystitis; Cytarabine; Drug Therapy, Combination; Female; Germany, East; Humans; Leukemia; Male; Methotrexate; Mycoses; Stomatitis; Transplantation, Autologous; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 1984 |
Combination chemotherapy involving alpha-difluoromethylornithine and 1-beta-D-arabinofuranosylcytosine in murine L1210 leukemia.
Topics: Animals; Body Weight; Bone Marrow; Bone Marrow Cells; Cell Cycle; Cytarabine; Drug Therapy, Combination; Eflornithine; Erythrocyte Count; Female; Leukemia L1210; Leukocyte Count; Longevity; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Ornithine; Polyamines | 1983 |
Assessment of the utility of postnatal testing following prenatal exposure to forty chemicals.
Topics: Abnormalities, Drug-Induced; Aging; Animals; Body Weight; Cricetinae; Cytarabine; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Evaluation Studies as Topic; Female; Gestational Age; Herbicides; Male; Mice; Mortality; Motor Activity; Phenyl Ethers; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains; Reproduction; Teratogens | 1983 |
Modulation of cytarabine uptake and toxicity by dipyridamole.
Topics: Animals; Biological Transport; Body Weight; Cell Line; Cytarabine; Dipyridamole; Drug Evaluation, Preclinical; Drug Interactions; Humans; Kinetics; Leukemia L1210; Mice | 1984 |
Comparison of the neonatal toxicity of two antiviral agents: vidarabine phosphate and cytarabine.
Topics: Animals; Animals, Newborn; Antiviral Agents; Body Weight; Brain; Cytarabine; Female; Gestational Age; Growth; Hair; Organ Size; Pregnancy; Rats; Sex Factors; Vidarabine | 1982 |
Adriamycin-induced delayed erythropoietic injury expressed following anemia stress.
Topics: Anemia; Animals; Body Weight; Bone Marrow; Cytarabine; Doxorubicin; Erythropoiesis; Female; Femur; Iron; Mice; Organ Size; Spleen | 1980 |
Pulsed magnetic field from video display terminals enhances teratogenic effects of cytosine arabinoside in mice.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Bone and Bones; Calcification, Physiologic; Cleft Lip; Cleft Palate; Computer Terminals; Cytarabine; Electromagnetic Fields; Female; Fetal Death; Fetal Resorption; Male; Mice; Pregnancy | 1995 |
Collection and transplantation of peripheral blood stem cells in very small children weighting 20 kg or less.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Blood Preservation; Body Weight; Bone Marrow Diseases; Carboplatin; Catheterization, Central Venous; Catheters, Indwelling; Child, Preschool; Cisplatin; Colony-Forming Units Assay; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Male; Neoplasms; Platelet Transfusion; Retrospective Studies; Safety | 1995 |
Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Antineoplastic Agents; Body Weight; Chitin; Chitosan; Cytarabine; Drug Carriers; Hydrogen-Ion Concentration; Leukemia P388; Longevity; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred Strains; Prodrugs; Spectrophotometry, Ultraviolet | 1993 |
Polyamine increase in rat tissues treated with 1-beta-D-arabinosylcytosine and 5-fluorouracil.
Topics: Animals; Body Weight; Chromatography, High Pressure Liquid; Cytarabine; Fluorouracil; Male; Neoplasms, Experimental; Organ Size; Polyamines; Rats; Rats, Sprague-Dawley | 1993 |
Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats.
Topics: Animals; Animals, Suckling; Antimetabolites, Antineoplastic; Body Weight; Bone Marrow; Bone Marrow Cells; Cholesterol; Cytarabine; Diarrhea; Diet; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Hair; Heart; Hematopoietic Stem Cells; Immunosuppressive Agents; Liver; Male; Muscle, Skeletal; Myocardium; Phospholipids; Rats; Rats, Inbred F344; Tissue Distribution; Triglycerides | 1997 |
Effects of 2'-deoxycoformycin, 9-beta-D-arabinofuranosyladenine 5'-phosphate, and 1-beta-D-arabinofuranosylcytosine triple combination therapy on intracerebral leukemia 1210.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Azepines; Body Weight; Brain; Brain Neoplasms; Cytarabine; Deoxyribonucleotides; Drug Synergism; Drug Therapy, Combination; Female; In Vitro Techniques; Kinetics; Leukemia L1210; Mice; Mice, Inbred DBA; Vidarabine | 1977 |
[Therapy of non-lymphoid acute leukemias].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Body Weight; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Middle Aged; Remission, Spontaneous; Thioguanine; Vincristine | 1975 |
Effect of bleeding on hematopoiesis following irradiation and marrow transplantation.
Topics: Animals; Body Weight; Bone Marrow Cells; Bone Marrow Transplantation; Cytarabine; Erythropoiesis; Female; Hematocrit; Hemorrhage; Iron Radioisotopes; Mice; Organ Size; Radiation Chimera; Radiation Effects; Spleen | 1975 |
A comparison of the effects of cytosine arabinoside and adenine arabinoside on some aspects of brain growth and development in the rat.
Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Brain; Cerebellum; Cytarabine; Discrimination Learning; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Maternal-Fetal Exchange; Pregnancy; Purine Nucleosides; Rats; Vidarabine | 1975 |
A novel note on the effect of ara-C on the polyamine content of the male accessory organs of the rat.
Topics: Animals; Body Weight; Cytarabine; Genitalia, Male; Male; Organ Size; Polyamines; Rats; Rats, Inbred Strains | 1992 |
Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation.
Topics: Animals; Body Weight; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line; Cyclophosphamide; Cytarabine; Female; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Immunologic Deficiency Syndromes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Transplantation, Heterologous | 1991 |
Maternal and developmental toxicity of low doses of cytosine arabinoside in mice.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Cytarabine; Feeding Behavior; Female; Fetal Death; Fetal Resorption; Litter Size; Maternal-Fetal Exchange; Mice; Pregnancy; Teratogens | 1991 |
Effects of high dose intraperitoneal cytosine arabinoside on the radiation tolerance of the rat spinal cord.
Topics: Animals; Body Weight; Cytarabine; Dose-Response Relationship, Radiation; Injections, Intraperitoneal; Male; Necrosis; Radiation Tolerance; Rats; Rats, Inbred Strains; Spinal Cord Diseases | 1989 |
The effect of pretreatment with thio-TEPA and cytosine arabinoside on megakaryocytopoiesis in rats given a sublethal dose of thio-TEPA.
Topics: Animals; Body Weight; Cytarabine; Hematopoiesis; Intestinal Mucosa; Male; Megakaryocytes; Melphalan; Rats; Rats, Inbred Lew; Species Specificity; Thiotepa; Time Factors | 1987 |
Study on the long-term toxic efficacy of cytosine-arabinoside in Sprague-Dawley rats.
Topics: Animals; Body Weight; Colony-Forming Units Assay; Cytarabine; Female; Hematopoietic Stem Cells; Male; Neoplasms; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Microwave radiation enhances teratogenic effect of cytosine arabinoside in mice.
Topics: Abnormalities, Drug-Induced; Abnormalities, Radiation-Induced; Animals; Body Weight; Cytarabine; Female; Fetal Death; Microwaves; Pregnancy; Rats | 1986 |
Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Basophils; Blood Cell Count; Body Weight; Bone Marrow Cells; Busulfan; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Female; Hemoglobins; Humans; Hydroxyurea; Leukemia, Myeloid; Male; Middle Aged; Philadelphia Chromosome; Prednisone; Prognosis; Risk; Vincristine | 1985 |
Therapeutic effects of melengestrol acetate, cyclophosphamide and palmitoyl cytarabine in established experimental allergic encephalomyelitis of rats.
Topics: Adrenal Glands; Animals; Body Weight; Brain; Cyclophosphamide; Cytarabine; Encephalomyelitis, Autoimmune, Experimental; Erythrocyte Count; Female; Hematocrit; Hemoglobins; Leukocyte Count; Liver; Melengestrol Acetate; Organ Size; Palmitic Acids; Paralysis; Pregnanediones; Progestins; Rats; Spinal Cord; Spleen; Staining and Labeling; Thymus Gland; Time Factors | 1973 |
Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine (ARA-C) deamination in several species.
Topics: Animals; Body Weight; Cytarabine; Deamination; Digestive System; Dogs; Haplorhini; Humans; In Vitro Techniques; Kidney; Kinetics; Liver; Macaca; Mathematics; Mice; Mice, Inbred Strains; Models, Biological; Muscles; Myocardium; Species Specificity; Time Factors; Tritium | 1973 |
Effect of the antiviral drug, cytosine arabinoside, on the developing nervous system.
Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Brain; Brain Diseases; Cell Differentiation; Cerebellum; Cytarabine; Female; Gait; Hair; Hematopoietic System; Male; Mice; Organ Size; Retina | 1974 |
Hyponatraemia syndrome in acute myeloid leukaemia.
Topics: Adult; Ampicillin; Blood Cell Count; Body Weight; Bone Marrow Cells; Chlorides; Cloxacillin; Cytarabine; Daunorubicin; Diet; Female; Fever; Food Analysis; Gentamicins; Humans; Hyponatremia; Leukemia, Myeloid, Acute; Male; Middle Aged; Nitrogen; Osmolar Concentration; Potassium; Sodium; Syndrome; Urea | 1974 |
Antagonism between inhibitors of DNA synthesis.
Topics: Animals; Body Weight; Cytarabine; Drug Combinations; Leukemia; Male; Meninges; Methotrexate; Mice; Mice, Inbred CBA; Rats; Rats, Inbred Strains | 1972 |
Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation.
Topics: Adolescent; Adult; Aged; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclophosphamide; Cytarabine; Erythrocytes; Female; Humans; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Neoplasms; Osmolar Concentration; Serum Albumin; Sodium; Time Factors; Urine; Water Intoxication | 1973 |
Animal scale-up.
Topics: Animals; Biological Transport; Biotransformation; Body Weight; Chlorides; Cytarabine; Dialysis; Diffusion; Humans; Kinetics; Mammals; Methotrexate; Models, Biological; Organ Specificity; Pharmaceutical Preparations; Pharmacology; Species Specificity; Thermodynamics; Thiopental; Time Factors | 1973 |
Induction and characteristics of resistance to L-asparaginase (NSC-109229) in mouse leukemia L5178Y.
Topics: Amino Acids; Animals; Asparaginase; Azaserine; Body Weight; Cytarabine; Drug Resistance; Female; Leukemia, Experimental; Male; Methotrexate; Mice; Neoplasm Transplantation; Time Factors | 1971 |
Hematological toxicity of 1-beta-D-arabinofuranosylcytosine, and its prevention by deoxycytidine, in the mouse.
Topics: Animals; Blood Cell Count; Blood Platelets; Body Weight; Bone Marrow; Bone Marrow Cells; Cytarabine; Cytosine Nucleotides; Erythrocytes; Hematocrit; Hemoglobins; Leukocytes; Male; Mice | 1971 |